Search

Revvity Inc

Geschlossen

BrancheGesundheitswesen

143.55 0.03

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

142.19

Max

145.21

Schlüsselkennzahlen

By Trading Economics

Einkommen

13M

53M

Verkäufe

19M

730M

KGV

Branchendurchschnitt

61.774

56.432

EPS

1.41

Dividendenrendite

0.23

Gewinnspanne

7.329

Angestellte

11,000

EBITDA

8.8M

189M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-11.21% downside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.23%

2.27%

Nächstes Ergebnis

26. Okt. 2026

Nächste Dividendenausschüttung

13. Nov. 2026

Nächstes Ex-Dividendendatum

23. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.5B

14B

Vorheriger Eröffnungskurs

143.52

Vorheriger Schlusskurs

143.55

Nachrichtenstimmung

By Acuity

19%

81%

20 / 339 Ranking in Healthcare

Revvity Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Sept. 2026, 23:56 UTC

Revvity Inc is trading modestly higher in after-market hours, positioned above its 20-day moving average and near the upper end of its one-month range.

16. Sept. 2026, 20:07 UTC

Revvity Inc is trading higher, continuing a strong momentum with four consecutive sessions of gains and remaining well above its 20-day moving average.

15. Sept. 2026, 22:02 UTC

Revvity Inc. shares are lower in after-market trading, reflecting broader market trends amid economic concerns following a significant drop in the NY Empire State Manufacturing Index.

14. Sept. 2026, 20:08 UTC

Revvity Inc shares are higher in Monday's session, continuing a broader upward trend since Friday. The stock is above its 20-day moving average.

11. Sept. 2026, 20:08 UTC

News

Revvity Inc will acquire Human Cell Design to enhance its Life Sciences sector reach. Shares are rising today after five consecutive lower sessions.

9. Sept. 2026, 20:07 UTC

News
Event

Revvity Inc announced its acquisition of Human Cell Design to enhance its Life Sciences portfolio. Shares are trading lower amid broader market weakness.

8. Sept. 2026, 20:07 UTC

Revvity Inc shares are lower today, continuing a decline since Friday's close. The stock opened down and remained weak throughout the session.

4. Sept. 2026, 19:47 UTC

News

Revvity Inc shares are lower amid mixed analyst ratings and price target adjustments. Earlier, shares pulled back from a session high during ongoing market volatility.

3. Sept. 2026, 20:07 UTC

News

Revvity Inc shares are lower today, reaching a low of -2.18%. Analyst Catherine Ramsey Schulte raised the price target to $144.00 from $131.00.

2. Sept. 2026, 21:02 UTC

Revvity Inc shares are higher in after-market trading, with no specific news identified. The broader market context includes a disappointing ADP employment report.

1. Sept. 2026, 19:43 UTC

News

Revvity shares are lower as RBC Capital initiates coverage with a Sector Perform rating and a price target of $135.

31. Aug. 2026, 20:07 UTC

Revvity Inc shares are lower amid broader market reactions to inflation comments from Warsh at the Jackson Hole Economic Symposium.

28. Aug. 2026, 22:51 UTC

Revvity Inc shares are trading lower in after-market hours. No specific news was identified to explain this movement amid overall weak market performance.

27. Aug. 2026, 20:07 UTC

Revvity Inc shares are higher, continuing a trend of gains since Wednesday. The stock remains above its 20-day moving average with four consecutive higher closes.

26. Aug. 2026, 19:16 UTC

Revvity Inc shares are higher, supported by strong performance metrics and trading above the 20-day moving average. No specific news was identified for this move.

25. Aug. 2026, 21:02 UTC

Revvity Inc. shares are trading lower in after-market hours, despite remaining above their 20-day moving average and near the upper end of their one-month range.

24. Aug. 2026, 19:56 UTC

Revvity Inc. shares are lower today, having reached a session low earlier. Broader market pressures include economic concerns related to U.S.-Iran relations.

21. Aug. 2026, 23:51 UTC

Revvity Inc shares are trading lower in after-market hours. The decline follows a consistent downward trend since Friday's close, despite remaining above the 20-day moving average.

20. Aug. 2026, 22:01 UTC

Revvity Inc shares are lower in after-market trading, continuing a decline since Thursday's close, despite being above its 20-day moving average.

19. Aug. 2026, 23:11 UTC

Revvity Inc shares are higher in after-market trading, maintaining gains above the 20-day moving average and near the top of their one-month range.

17. Aug. 2026, 19:46 UTC

News

RVTY shares lower after analyst downgrades from JPMorgan, Stifel.

14. Aug. 2026, 20:13 UTC

Revvity Inc shares are lower in after-market trading, with no specific news driving the decline. Broader market trends include a drop in U.S. retail sales.

13. Aug. 2026, 19:46 UTC

News

Revvity shares are lower despite Q2 revenue and non-GAAP earnings growth. Analysts raised concerns about segment dynamics and competitive challenges following the earnings report.

12. Aug. 2026, 19:46 UTC

Revvity Inc shares are higher today, supported by positive market sentiment following a favorable inflation report and strong quarterly results from technology companies.

11. Aug. 2026, 20:13 UTC

Revvity Inc. shares are trading roughly flat after-market hours, with market sentiment influenced by expectations for the upcoming Consumer Price Index report.

10. Aug. 2026, 22:01 UTC

Revvity Inc shares are trading higher in after-market hours, following broader market dynamics and reduced expectations for Federal Reserve rate hikes.

7. Aug. 2026, 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6. Aug. 2026, 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5. Aug. 2026, 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4. Aug. 2026, 19:51 UTC

Social Media
News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

Peer-Vergleich

Kursveränderung

Revvity Inc Prognose

Kursziel

By TipRanks

-11.21% Nachteil

12-Monats-Prognose

Durchschnitt 127.364 USD  -11.21%

Hoch 165 USD

Tief 110 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Revvity Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

13 ratings

4

Buy

9

Halten

0

Sell

Stimmung

By Acuity

20 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.